TradingView
MarketMoversReport
7 lip 2022 17:47

Intercept Announces Positive Data in Fibrosis due to NASH Long

Opis

ICPT: Intercept Pharmaceuticals, Inc.
2022-07-07 07:30:00
Intercept Announces Positive Data in Fibrosis due to NASH from a New Analysis of its Phase 3 REGENERATE Study of Obeticholic Acid (OCA)
Więcej